Exercise of a Second Drawing Request under Equity Funding Agreement with Goldman Sachs

Liege, Belgium, 21 March 2022 – 17:45 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that it has exercised a second drawing request for an amount of EUR 5 million, according to the terms of the equity funding agreement signed with Goldman Sachs […]

Read more

Mithra Reports Full Year 2021 Financial Results

Liege, Belgium, 08 March 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces its financial results for the year ended 31 December 2021, prepared in accordance with IFRS.

Read more

Publication of a Transparency Notification Received from François Fornieri

Liege, Belgium, 28 February 2022 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]

Read more

Publication of a Transparency Notification Received from Alychlo

Liege, Belgium, 25 February 2022 – 7:35 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that […]

Read more

Publication of a Transparency Notification Received from Goldman Sachs

Liege, Belgium, 25 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]

Read more

Mithra to Host Webcast for 2021 Financial Results on 8 March 2022

Liege, Belgium, 21 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health announces that it will host a live webcast on Tuesday, 8 March 2022 at 09:00 CET to present its 2021 financial and operating results. The live webcast can be accessed on the Mithra website or by […]

Read more

Mithra and Searchlight Pharma Announce Launch of Haloette® in Canada

LIEGE (Belgium – 7:30 AM CET) and MONTREAL (Canada – 7:00 AM EST), February 16, 2022 – Mithra and Searchlight Pharma are pleased to announce the commercial launch of Mithra’s vaginal contraceptive ring Myring® under the brandname Haloette® in Canada.

Read more

Publication of a Transparency Notification Received from François Fornieri

Liege, Belgium, 16 February 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), […]

Read more

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase

Liege, Belgium, 14 February 2022 – 17:45 CET – In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below […]

Read more

Mithra Obtains Equity Funding for up to EUR 100 Million

Liege, Belgium, 7 February 2022 – 07:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to women’s health, today announces that it has entered into an equity financing agreement with Goldman Sachs International (“GSI”), pursuant to which the Company can at its sole discretion require GSI (subject to […]

Read more